A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding

被引:29
作者
Mccandless, Lawrence C. [1 ]
Gustafson, Paul [1 ]
Levy, Adrian R. [2 ,3 ]
机构
[1] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1Z2, Canada
[2] Univ British Columbia, Dept Healthcare & Epidemiol, Vancouver, BC V6T 1Z2, Canada
[3] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada
关键词
unmeasured confounding; bias; observational studies; sensitivity analysis; Bayesian statistics; pharmacoepidemiology;
D O I
10.1016/j.jclinepi.2007.05.006
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: In the analysis of observational data, the argument is sometimes made that if adjustment for measured confounders induces little change in the treatment-outcome association, then there is less concern about the extent to which the association is driven by unmeasured confounding. We quantify this reasoning using Bayesian sensitivity analysis (BSA) for unmeasured confounding. Using hierarchical models, the confounding effect of a binary unmeasured variable is modeled as arising from the same distribution as that of measured confounders. Our objective is to investigate the performance of the method compared to sensitivity analysis, which assumes that there is no relationship between measured and unmeasured confounders. Study Design and Setting: We apply the method in an observational study of the effectiveness of beta-blocker therapy in heart failure patients. Results: BSA for unmeasured confounding using hierarchical prior distributions yields an odds ratio (OR) of 0.72, 95% credible interval (CrI): 0.56, 0.93 for the association between beta-blockers and mortality, whereas using independent priors yields OR = 0.72, 95% CrI: 0.45, 1.15. Conclusion: If the confounding effect of a binary unmeasured variable is similar to that of measured confounders, then conventional sensitivity analysis may give results that overstate the uncertainty about bias. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:247 / 255
页数:9
相关论文
共 22 条
[11]  
2-U
[12]   Risk-treatment mismatch in the pharmacotherapy of heart failure [J].
Lee, DS ;
Tu, JV ;
Juurlink, DN ;
Alter, DA ;
Ko, DT ;
Austin, PC ;
Chong, A ;
Stukel, TA ;
Levy, D ;
Laupacis, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (10) :1240-1247
[13]   Bayesian sensitivity analysis for unmeasured confounding in observational studies [J].
McCandless, Lawrence C. ;
Gustafson, Paul ;
Levy, Adrian .
STATISTICS IN MEDICINE, 2007, 26 (11) :2331-2347
[14]   A new casemix adjustment index for hospital mortality among patients with congestive heart failure [J].
Polanczyk, CA ;
Rohde, LEP ;
Philbin, EA ;
Di Salvo, TG .
MEDICAL CARE, 1998, 36 (10) :1489-1499
[15]   Assessment and control for confounding by indication in observational studies [J].
Psaty, BM ;
Koepsell, TD ;
Lin, DY ;
Weiss, NS ;
Siscovick, DS ;
Rosendaal, FR ;
Pahor, M ;
Furberg, CD .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (06) :749-754
[16]  
R Development Core Team, 2004, R LANG ENV STAT COMP
[18]   Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics [J].
Schneeweiss, Sebastian .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (05) :291-303
[19]   The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure [J].
Sin, DD ;
McAlister, FA .
AMERICAN JOURNAL OF MEDICINE, 2002, 113 (08) :650-656
[20]  
Walker AM, 1996, EPIDEMIOLOGY, V7, P335